BREAST METASTATIC MARKER
181 Ratings
Rs 6,500 Rs 5,000
23 % OFF
ER & PR RECEPTOR ASSAYS ARE ROUTINELY PERFORMED ON BREAST CARCINOMAS TO ASSESS RESPONSIVENESS TO ENDOCRINE THERAPY AND PROGNOSIS. CA 15.3 IS USEFUL FOR MONITORING RESPONSE TO TREATMENT AND IF ELEVATED SUGGESTS RECURRENCE IN WOMEN WITH STAGE II OR III BREAST CANCER.
Why book with us?
-
Free and On Schedule Sample Collection
-
24/7 Service
-
Affordable
-
Quick and Accurate Reports
SUBMIT TUMOUR TISSUE IN 10% FORMAL-SALINE OR FORMALIN FIXED PARAFFIN EMBEDDED TISSUE BLOCK. SHIP AT ROOM TEMPERATURE. PROVIDE A COPY OF THE HISTOPATHOLOGY REPORT. INDICATE SITE OF BIOPSY AND PROVIDE CLINICAL HISTORY AND 2 ML (1 ML MIN.) SERUM FROM 1 SST. SHIP REFRIGERATED OR FROZEN.
IHC, CLIA
REPORT ON 5TH DAY EVENING 7PM
PROVIDE A COPY OF THE HISTOPATHOLOGY REPORT, CLINICAL HISTORY & INDICATE SITE OF BIOPSY.
